BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36098934)

  • 1. Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease.
    Ziemssen T; Smolinski L; Członkowska A; Akgun K; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Redzia-Ogrodnik B; Litwin T
    Acta Neurol Belg; 2023 Jun; 123(3):917-925. PubMed ID: 36098934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
    Rędzia-Ogrodnik B; Członkowska A; Bembenek J; Antos A; Kurkowska-Jastrzębska I; Skowrońska M; Smoliński Ł; Litwin T
    Neurol Sci; 2022 Jul; 43(7):4405-4412. PubMed ID: 35275318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neurofilament light chain as a biomarker in Wilson's disease.
    Yang J; Huang Z; Yang H; Luo Y; You H; Chen D; Pei Z; Li X
    Parkinsonism Relat Disord; 2022 Feb; 95():5-10. PubMed ID: 34942565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations.
    Ziemssen T; Akgun K; Członkowska A; Antos A; Bembenek J; Kurkowska-Jastrzębska I; Przybyłkowski A; Skowrońska M; Smolinski L; Litwin T
    Mov Disord; 2022 May; 37(5):1074-1079. PubMed ID: 35114010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Neurofilament Light Chain in Wilson's Disease: A Promising Indicator but Unparallel to Real-Time Treatment Response.
    Wang RM; Xu WQ; Zheng ZW; Yang GM; Zhang MY; Ke HZ; Xia N; Dong Y; Wu ZY
    Mov Disord; 2022 Jul; 37(7):1531-1535. PubMed ID: 35507442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of clinical rating scales in Wilson's disease.
    Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
    BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography as a marker of neurodegeneration in patients with Wilson's disease.
    Langwińska-Wośko E; Litwin T; Dzieżyc K; Karlinski M; Członkowska A
    Acta Neurol Belg; 2017 Dec; 117(4):867-871. PubMed ID: 28488258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early neurological worsening in patients with Wilson's disease.
    Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
    J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis.
    Antos A; Członkowska A; Smolinski L; Bembenek J; Przybyłkowski A; Skowrońska M; Kurkowska-Jastrzębska I; Litwin T
    Neurol Sci; 2023 Oct; 44(10):3443-3455. PubMed ID: 37311952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
    Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
    BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treatment on blood-brain barrier impairment in Wilson's disease.
    Misztal M; Członkowska A; Cudna A; Palejko A; Litwin T; Piechal A; Kurkowska-Jastrzębska I
    Neurol Neurochir Pol; 2023; 57(4):379-386. PubMed ID: 37526174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale networks changes in Wilson's disease associated with neuropsychiatric impairments: a resting-state functional magnetic resonance imaging study.
    Wang A; Dong T; Wei T; Wu H; Yang Y; Ding Y; Li C; Yang W
    BMC Psychiatry; 2023 Nov; 23(1):805. PubMed ID: 37924073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.
    De Fabregues O; Viñas J; Palasí A; Quintana M; Cardona I; Auger C; Vargas V
    Brain Behav; 2020 May; 10(5):e01596. PubMed ID: 32202078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free water imaging as a novel biomarker in Wilson's disease: A cross-sectional study.
    Jing XZ; Li GY; Wu YP; Yuan XZ; Luo XG; Chen JL; Taximaimaiti R; Wang XP; Li JQ
    Parkinsonism Relat Disord; 2023 Jan; 106():105234. PubMed ID: 36481719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
    Shribman S; Heller C; Burrows M; Heslegrave A; Swift I; Foiani MS; Gillett GT; Tsochatzis EA; Rowe JB; Gerhard A; Butler CR; Masellis M; Bremner F; Martin A; Jung L; Cook P; Zetterberg H; Bandmann O; Rohrer JD; Warner TT
    Mov Disord; 2021 Feb; 36(2):503-508. PubMed ID: 33078859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale.
    Członkowska A; Litwin T; Dzieżyc K; Karliński M; Bring J; Bjartmar C
    BMC Neurol; 2018 Apr; 18(1):34. PubMed ID: 29621974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Atrophy Is Substantially Accelerated in Neurological Wilson's Disease: A Longitudinal Study.
    Smolinski L; Ziemssen T; Akgun K; Antos A; Skowrońska M; Kurkowska-Jastrzębska I; Członkowska A; Litwin T
    Mov Disord; 2022 Dec; 37(12):2446-2451. PubMed ID: 36165286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.
    Laurencin C; Brunet AS; Dumortier J; Lion-Francois L; Thobois S; Mabrut JY; Dubois R; Woimant F; Poujois A; Guillaud O; Lachaux A; Broussolle E
    Eur Neurol; 2017; 77(1-2):5-15. PubMed ID: 27866189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory rTMS applied on somatosensory cortex in Wilson's disease patients with hand dystonia.
    Lozeron P; Poujois A; Meppiel E; Masmoudi S; Magnan TP; Vicaut E; Houdart E; Guichard JP; Trocello JM; Woimant F; Kubis N
    J Neural Transm (Vienna); 2017 Oct; 124(10):1161-1170. PubMed ID: 28689295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.
    Li LY; Yang WM; Chen HZ; Wu YH; Fang X; Zhang J; Wang Z; Han YS; Wang Y
    PLoS One; 2015; 10(4):e0124569. PubMed ID: 25910248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.